Lamotrigine, an anticonvulsant and mood stabilizer, acts by modulating voltage-gated sodium channels and reducing glutamate release, which may help mitigate the neurological dysregulation associated with Visual Snow Syndrome. By stabilizing neuronal membranes and potentially attenuating aberrant cortical hyperexcitability, it can potentially reduce visual disturbances and sensory processing abnormalities characteristic of the syndrome.